free shipping visit free shipping affordable Ami Alexandre Mattiussi derbies buy cheap low cost dTRaR

SKU-7751938242
free shipping visit free shipping affordable Ami Alexandre Mattiussi derbies buy cheap low cost dTRaR
Ami Alexandre Mattiussi derbies
outlet best sale Good For Nothing Sliders In Black With Logo explore cheap online sale many kinds of cheap sale amazing price G5XZndDE1
X Close Message Box

It seems you're using a browser version we no longer support. To get the best online experience, please consider upgrading to one of the following newer browsers.

Google Chrome sale fashionable Gianvito Rossi pointed toe pumps outlet locations for sale with credit card free shipping 1eS7TSb9vp
buy cheap wholesale price cheap sale sale Hogan Olympia X sneakers KpEYWQkQKi
Plein Sport Runner Ksistof sneakers sale online hu5Pw9oMUx
sale view affordable for sale Ports 1961 knot front mules iBQVWSx
La Redoute Collections Aztec Leather Ankle Boots huge surprise online clearance purchase eastbay cheap price for sale buy authentic online qiNOHD
discount collections shop Dolce Vita Rayne sandals sale order Cheapest online latest collections cheap price ql0qA
GlobeNewswire
deals for sale Vans hitop lace up sneakers clearance classic cheap sale big sale oLY3RUh
Sign In
buy cheap original Orlebar Brown Larson Panelled Mesh Sneakers outlet exclusive cheapest price cheap comfortable cheap finishline TYAl02PI
Journee Collection Womens Studded KneeHigh Riding Boots under 70 dollars cheap official outlet big sale 02uiHkuz

Topline results from the first of three Phase 3 trials in psoriasis clinical development program

Share
| Source: Dermira, Inc.

BRUSSELS, Belgium and MENLO PARK, Calif., Oct. 03, 2016 (GLOBE NEWSWIRE) -- UCB (Euronext:UCB) and Dermira, Inc. (NASDAQ:) today announced topline results from CIMPASI-2, a Phase 3, multi-center, placebo-controlled clinical trial evaluating the efficacy and safety of CIMZIA® (certolizumab pegol) in adult patients with moderate-to-severe chronic plaque psoriasis. In the CIMPASI-2 trial, CIMZIA demonstrated statistically significant improvements for both co-primary endpoints compared to placebo at both treatment doses. The CIMPASI-2 trial results are from the first of three Phase 3 clinical trials to be reported evaluating CIMZIA in this patient population. 1

The co-primary endpoints evaluated in the trial were the percentage of patients who achieved a 75% or greater disease improvement from baseline as measured by the Psoriasis Area and Severity Index (PASI 75) and the percentage of patients achieving at least a two-point improvement on a five-point Physician’s Global Assessment (PGA) scale to a final score representing clear or almost clear skin, each compared with placebo, at week 16. 1

A total of 227 patients with moderate-to-severe chronic plaque psoriasis were randomized to three dosing arms—400 mg every two weeks (n=87), 400 mg at weeks 0, 2, and 4 followed by 200 mg every two weeks (n=91), or placebo every two weeks (n=49). At week 16, the response rate for patients who achieved a PASI 75 was 82.6% for patients receiving the 400 mg dose every two weeks and 81.4% for patients receiving the 200 mg dose every two weeks, compared to 11.6% for patients receiving placebo. The response rate for patients achieving at least a two-point improvement to a final score of clear or almost clear skin on the PGA scale at week 16 was 71.6% for the 400 mg dose-treated patients and 66.8% for the 200 mg dose-treated patients, compared to 2.0% for the patients receiving placebo. CIMZIA demonstrated statistically significant improvements from baseline to week 16 relative to placebo for both co-primary endpoints at both treatment doses. The adverse event profile appears consistent with the adverse event profiles observed with CIMZIA in other indications. 1

“The clinical results from the CIMPASI-2 trial are very encouraging and reinforce our belief that CIMZIA may provide clinically meaningful benefit for moderate-to-severe plaque psoriasis patients,” said Tom Wiggans, chairman and chief executive officer of Dermira. “We look forward to data from the two additional ongoing Phase 3 clinical trials, which are expected by the end of the first quarter of 2017.”

Limited time offer: Use code 'FLYJULY18' for 3 months of FREE hosting!

Limited time offer:
outlet visit new sale 2014 unisex Marni brown 60 leather square toe mules latest collections sale online fashionable sale online Eb8F9rk

Never share passwords or create multiple logins again

•••

Streamline your collaboration process

You know you’ve done it — you’ve totally built a spreadsheet with all your client passwords in one place. Flywheel does away with all that. Collaborate easily and instantly with your team without the clunkiness of sharing and storing (and losing. And recovering) passwords.

Fifty and Fifty spends more time building client projects and zero time managing servers

Bryan Monzon is the vice president of engineering at Fifty and Fifty, a company that works on digital products (small and large) for social good. Since starting on Flywheel, Fifty and Fifty have sped up their project complete time and eliminated workflow headaches along the way.

DOWNLOAD

Ditch the spreadsheet filled with passwords. Never ask a client for a password again. Collaborators on Flywheel log in with their own usernames and passwords. They can view and manage all their sites in one place.

Add teammates and clients as collaborators, and they’ll get full access to manage the site, update files, and manage the database.

•••

It’s okay to fall in love with your Flywheel dashboard. Look how pretty it is, showing all the sites you own right next to the ones where you’re a collaborator. With just one login, you can manage all your sites, upload files via SFTP, and modify databases.

When the project is over, remove access from people who don’t need it anymore, and voilà! No more access.

Charlotte Olympia platform opentoe sandals clearance for cheap TmgprnCwlz

Wyman Projects uses Flywheel to centralize their workflow

View more stories

Try it yourself. It's free takes less than 60 seconds. buy cheap extremely LifeStride Playful Womens Ballet Flats sale footlocker pictures buy cheap visit SyzfEtjs

Reimagined SFTP

You know you’ve done it – a spreadsheet with all your client passwords in one place. Flywheel frees you from the need to share and store passwords.

Dr Martens Modern Classics Smooth 1460 8Eye Boots cheap limited edition aaOcg1n1
•••
•••

Test out changes in a test enviroment and easily push to production.

Sleep soundly at night knowing that all your important files are backed up nightly.

When you're done developing, easily transfer a site to your client for payment.

Powerful Tools

Managed Hosting

We'd love hearing from you. Give us a call and we can chat about your needs.

See for yourself how Flywheel can make your life easier.

© GG.COM 2018 | Always Gamble Responsibly 18+ v5.31.1 | Served in 0.21s by frontend-03